Latest news
29-09-2024 - PACE Launches £5 Million Call to Develop Innovative Diagnostics for Bacterial Infections
Pathways to Antimicrobial Clinical Efficacy (PACE) is a £30 million programme funded by LifeArc and Innovate UK and delivered by the Medicines Discovery Catapult. Its objective is to tackle the growing challenge of antimicrobial resistance (AMR) by providing project funding and other mentoring and innovation support to help accelerate the progression of early-stage, preclinical antimicrobial drug discovery and diagnostic projects. By targeting its support on early-stage, novel therapeutics and diagnostics, PACE is seeking to foster an exciting and diverse pipeline of preclinical phase projects aimed at combating bacterial infections with high unmet need.
[...]